| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.026 | 0.5 |